EFFECTS OF BIOLOGIC THERAPY IN PRIMARY SCLEROSING CHOLANGITIS WITH AND WITHOUT INFLAMMATORY BOWEL DISEASE: A SYSTEMATIC REVIEW AND META-ANALYSIS

被引:0
作者
Callaghan, Gavin B.
Shah, Ayesha
Fairlie, Thomas
Jones, Michael P.
Holtmann, Gerald J.
机构
关键词
D O I
暂无
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
Sa1142
引用
收藏
页码:S299 / S300
页数:2
相关论文
共 50 条
[41]   Efficacy and safety of immune-modulating therapy for primary sclerosing cholangitis: A systematic review and meta-analysis [J].
Liu, Xin ;
Wang, Haolu ;
Liu, Xinyao ;
Bridle, Kim ;
Crawford, Darrell ;
Liang, Xiaowen .
PHARMACOLOGY & THERAPEUTICS, 2022, 237
[42]   Hyperbaric oxygen therapy in inflammatory bowel disease: a systematic review and meta-analysis [J].
Singh, Anupam Kumar ;
Jha, Daya Krishna ;
Jena, Anuraag ;
Kumar-M, Praveen ;
Sebastian, Shaji ;
Sharma, Vishal .
EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY, 2021, 33 :E564-E573
[43]   Hyperbaric oxygen therapy in inflammatory bowel disease: a systematic review and meta-analysis [J].
Singh, Anupam Kumar ;
Jha, Daya Krishna ;
Jena, Anuraag ;
Kumar-M, Praveen ;
Sebastian, Shaji ;
Sharma, Vishal .
EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY, 2021, 33 (1S) :E564-E573
[44]   Efficacy of Immunosuppressive Therapy for Inflammatory Bowel Disease: A Systematic Review and Meta-Analysis [J].
Khan, Khurram J. ;
Dubinsky, Marla C. ;
Ford, Alexander C. ;
Ullman, Thomas A. ;
Talley, Nicholas J. ;
Moayyedi, Paul .
AMERICAN JOURNAL OF GASTROENTEROLOGY, 2011, 106 (04) :630-642
[45]   SAFETY OF BIOLOGIC THERAPY FOR INFLAMMATORY BOWEL DISEASE AMONG SOLID ORGAN TRANSPLANT RECIPIENTS: SYSTEMATIC REVIEW AND META-ANALYSIS [J].
Taneja, Vikas ;
Anand, Rajsavi ;
El-Dallal, Mohammed ;
Dong, Jeffrey ;
Desai, Nisa ;
Taneja, Isha ;
Feuerstein, Joseph D. .
GASTROENTEROLOGY, 2022, 162 (07) :S820-S820
[46]   Primary Sclerosing Cholangitis and Disease Distribution in Inflammatory Bowel Disease [J].
O'Toole, Aoibhlinn ;
Alakkari, Alaa ;
Keegan, Denise ;
Doherty, Glen ;
Mulcahy, Hugh ;
O'Donoghue, Diarmuid .
CLINICAL GASTROENTEROLOGY AND HEPATOLOGY, 2012, 10 (04) :439-441
[47]   Sclerosing cholangitis in inflammatory bowel disease:: diagnosis and therapy [J].
Broomé, U .
IBD AND SALICYLATES - 5, 2001, 24 (01) :181-190
[48]   SAFETY AND EFFICACY OF BIOLOGIC THERAPY FOR INFLAMMATORY BOWEL DISEASE IN LIVER TRANSPLANT RECIPIENTS FOR PRIMARY SCLEROSING CHOLANGITIS: A MULTICENTER EXPERIENCE [J].
Mousa, Omar Y. ;
Tse, Chung Sang ;
Sanchez, William ;
Keaveny, Andrew Paul ;
Kamath, Patrick S. ;
Harnois, Denise M. ;
Carey, Elizabeth J. ;
Picco, Michael F. ;
Loftus, Edward V. ;
Leighton, Jonathan A. ;
Lazaridis, Konstantinos N. ;
Watt, Kymberly ;
Eaton, John E. .
HEPATOLOGY, 2019, 70 :702A-703A
[49]   PRIMARY SCLEROSING CHOLANGITIS RECURRENCE AFTER LIVER TRANSPLANTATION: A SYSTEMATIC REVIEW AND META-ANALYSIS [J].
Numan, Laith ;
Al Momani, Laith ;
Husainat, Nedaa M. ;
Nehme, Fredy ;
Hamdeh, Shadi .
GASTROENTEROLOGY, 2020, 158 (06) :S1344-S1344
[50]   Association between appendectomy and risk of primary sclerosing cholangitis: A systematic review and meta-analysis [J].
Wijarnpreecha, Karn ;
Panjawatanan, Panadeekarn ;
Mousa, Omar Y. ;
Cheungpasitporn, Wisit ;
Pungpapong, Surakit ;
Ungprasert, Patompong .
CLINICS AND RESEARCH IN HEPATOLOGY AND GASTROENTEROLOGY, 2018, 42 (05) :436-442